Skip to main content

Cornerstone decision instructive on claims against directors for fiduciary breach

Alec Zadek, an experienced complex litigator in Mintz’s Boston office, authored this Massachusetts Lawyers Journal article discussing the Delaware Supreme Court’s ruling in the Cornerstone Therapeutics Inc. case that in the absence of non-exculpated claims from the plaintiffs, allegations that a director approved an interested transaction will not be sufficient for surviving that director’s motion to dismiss.